Delivery Order SPE2DB22D1106-SPE2DB24FEXE0

Award Date 6/14/24
Potential Completion Date 6/17/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $11,611.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens to support DLA's medical mission. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,319.97 to Amerisourcebergen Drug Corp's Corporate Office Division to supply the drug Trulicity 1.5 mg/0.5 ml pens. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,579.29 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Trulicity 4.5 mg/0.5 ml pens. This contract is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The Department of Defense's Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,161.12 to AmerisourceBergen Drug Corp's Corporate Office division. This contract is for the provision of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen with a completion date of June 10, 2024. The contract is a Firm Fixed Price agreement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $4,354.20 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Trulicity 1.5 mg/0.5 ml pen medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $5,727.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen, 0.5 ml. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which enables the DLA to efficiently...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,011.34 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. This delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens under an indefinite delivery contract with a potential value of $999,999,999.00 and a performance period through December 31, 2025. AmerisourceBergen Drug Corp is the prime contractor on this single award indefinite delivery contract to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,145.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds as the prime contractor, providing a comprehensive range of pharmaceuticals and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $3,212.94 firm fixed price contract is for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $3,019.30 to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical and medical...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEXE0
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,016.60 to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, and has a completion date of June 17, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's medical treatment programs and facilities globally. This contract award did not utilize any set-aside designations.

Generated 9/13/24, 10:04 AM